Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “OSTEOPOROSIS, POSTMENOPAUSAL”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00141323
What this trial is testing

Postmenopausal Evaluation and Risk-reduction With Lasofoxifene (PEARL)

Who this might be right for
Osteoporosis
Ligand Pharmaceuticals 8,556
Testing effectiveness (Phase 2)UnknownNCT03518268
What this trial is testing

Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor

Who this might be right for
Breast CancerOsteoporosis, Osteopenia
Tel-Aviv Sourasky Medical Center 40
Large-scale testing (Phase 3)Study completedNCT00000466
What this trial is testing

Postmenopausal Estrogen/Progestin Interventions (PEPI)

Who this might be right for
Bone DiseasesCardiovascular DiseasesCoronary Disease+8 more
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableUnknownNCT03435094
What this trial is testing

Effect of Alendronate 70mg Formulation on Bone Turnover Markers and Patient Reported Outcomes

Who this might be right for
Osteoporosis, Postmenopausal
Labatec Pharma SA 80
Post-approval studies (Phase 4)Study completedNCT00371956
What this trial is testing

Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid Therapy

Who this might be right for
Osteoporosis
Tuen Mun Hospital 114
Post-approval studies (Phase 4)Study completedNCT00082277
What this trial is testing

Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 237
Not applicableUnknownNCT03832075
What this trial is testing

Validity of Korebalance Balance System

Who this might be right for
Osteoporosis, PostmenopausalBalance; Distorted
Istanbul Medeniyet University 53
Large-scale testing (Phase 3)Study completedNCT00675688
What this trial is testing

Study Evaluating Safety and Efficacy of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopausal Women

Who this might be right for
Endometrial HyperplasiaOsteoporosis
Wyeth is now a wholly owned subsidiary of Pfizer 3,544
Large-scale testing (Phase 3)UnknownNCT05419427
What this trial is testing

Denosumab Biosimilar Injection in Post Menopausal Women With Osteoporosis

Who this might be right for
Osteoporosis, Postmenopausal
Lambda Therapeutic Research Ltd. 552
Large-scale testing (Phase 3)Study completedNCT00330096
What this trial is testing

Effects of Hesperidin on Bone Mineral Density and Bone Metabolism of Postmenopausal Women

Who this might be right for
Osteoporosis, Osteopenia
Société des Produits Nestlé (SPN) 110
Not applicableStudy completedNCT04167150
What this trial is testing

Tart Cherry Supplementation and Women's Bone Health Study

Who this might be right for
Osteoporosis, PostmenopausalOsteoporosis, Age-Related
Oklahoma State University 33
Large-scale testing (Phase 3)Study completedNCT06804590
What this trial is testing

A Study on Efficacy, Safety and Immunogenicity of 9MW0311 in Postmenopausal Women With Osteoporosis

Who this might be right for
Postmenopausal Women Osteoporosis
Mabwell (Shanghai) Bioscience Co., Ltd. 280
Post-approval studies (Phase 4)Study completedNCT00557310
What this trial is testing

A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With Teriparatide

Who this might be right for
Osteoporosis, Postmenopausal
Eli Lilly and Company 35
Testing effectiveness (Phase 2)Study completedNCT00293813
What this trial is testing

A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density

Who this might be right for
Postmenopausal Osteoporosis
Amgen 247
Large-scale testing (Phase 3)WithdrawnNCT01552122
What this trial is testing

Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Alendronate (MK-0822-050)

Who this might be right for
OsteoporosisPostmenopausal Osteoporosis
Merck Sharp & Dohme LLC
Post-approval studies (Phase 4)Study completedNCT00504166
What this trial is testing

Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal Women

Who this might be right for
OsteopeniaOsteoporosis
University of California, San Francisco 53
Not applicableStudy completedNCT01572545
What this trial is testing

Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin of Postmenopausal Women With Low Bone Mass

Who this might be right for
Postmenopausal Osteoporosis
Aristotle University Of Thessaloniki 91
Large-scale testing (Phase 3)Study completedNCT01387672
What this trial is testing

Nitrates and Bone Turnover; Nitrates and Bone Turnover Bisphosphonate Sub-Study

Who this might be right for
Osteoporosis
University of Toronto 265
Not applicableUnknownNCT01854086
What this trial is testing

Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday

Who this might be right for
Osteoporosis
Meir Medical Center 150
Testing effectiveness (Phase 2)Study completedNCT00545116
What this trial is testing

Effects of Hesperidin on Bone Biomarkers in Postmenopausal Women

Who this might be right for
OsteopeniaOsteoporosis
Société des Produits Nestlé (SPN) 144
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation